Medical Reporting/Vaccine and Treatment News

Medical Reporting and Research

Published for General Public Reading

Minimal Requirement of being a verified major news outlet with a high unbiased rating on The Media Bias Chart and/or from reputable sources, such as research facilities and universities

Strong recommendation to not take action or make assumptions based upon research which may be dated, changing or part of ongoing research

Treatment Options

• 10 APR 2020 FDA Letter to Stakeholders: Do Not Use Ivermectin Intended for Animals as Treatment for COVID-19 in Humans
• 10 APR 2020 France Reports Heart Incidents Linked to Drug Promoted by Trump
• 09 APR 2020 Over 80pct of COVID Patients Placed on Ventilators in New York City Have Died
• 09 APR 2020 NEWSTwo potential COVID-19 treatments could be deadly when combined with metformin
  • Two drugs which have been linked with treating coronavirus could be deadly when combined with metformin, researchers have said.
  • Hydroxychloroquine (HCQ) and chloroquine (CQ) are usually used to treat malaria and autoimmune diseases, and in America the Food and Drug Administration has authorised the two medications to be used in people in hospital with COVID-19.
    
  • The drugs have also shown promising outcomes in helping to treat certain cancers, but recent studies have also found combining these medications with metformin, sold as Glucophage, could be fatal.
  • A study which used mice to test the outcome of all three drugs, showed between 30% and 40% of the animals died.
• 08 APR 2020 Israeli COVID-19 treatment shows 100pct survival rate - preliminary data
• 07 APR 2020 eidd2801_fda/index.html FDA: Human trials can begin for Emory COVID-19 antiviral
• 04 APR 2020 COVID-19 Pandemic Has Only Just Begun
• 03 APR 2020 A small trial finds that hydroxychloroquine is not effective for treating coronavirus
• 26 MAR 2020 ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients
• 25 MAR 2020 Sweden bucks global trend with experimental virus strategy
• 24 MAR 2020 Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients - The Mount Sinai Health System this week plans to initiate a procedure known as plasmapheresis, where the antibodies from patients who have recovered from COVID-19 will be transferred into critically ill patients with the disease, with the expectation that the antibodies will neutralize it.
• 22 MAR 2020 WHO launches global megatrial of the four most promising coronavirus treatments

Viral Research

• 13 APR 2020WHO officials say it’s unclear whether recovered coronavirus patients are immune to second infection
• 12 APR 2020 Coronavirus could attack immune system like HIV by targeting protective cells, warn scientists
• 10 APR 2020 Scientists developing COVID-19 test that knows you’re sick before you do
• 10 APR 2020 False Negatives Raise Doctors' Doubts About Coronavirus Tests
• 10 APR 2020 Brain, Nervous System Affected in 1 in 3 Cases of Severe COVID-19
• 09 APR 2020 LXRZLFPZbd-Sd_uFISOYagsfsV6A8E4maARKO-ruMxp_94 Roseland Hospital phlebotomist: 30pct of those tested have coronavirus antibody
• 05 APR 2020 A (possible) solution to COVID-19This data suggests a simple and testable hypothesis –there are natural strains of SARS-CoV-2 in the world that have mutated to be non-pathogenic (asymptomatic or mild), but are still infective and will provide immunity to the more pathogenic (deadly) strains. -
• 27 MAR 2020 8 strains of the coronavirus are circling the globe. Here's what clues they're giving scientists.
  • Conclusions: Our findings suggest that patients with a shorter incubation period went on to have more severe disease. Further studies are needed to investigate potential biological mechanisms for this association.
• 27 MAR 2020 How sick will the coronavirus make you? The answer may be in your genes

Vaccine Research

• 03 APR 2020 Doctor's Note: Can you catch coronavirus twice?
• 03 APR 2020 Johnson & Johnson Announces Rapid Plan For Coronavirus Vaccine
• 02 APR 2020 COVID-19 Vaccine Candidate Shows Promise - 'emphasis on promise, not certain, not approved for human trials yet'
• 26 MAR 2020 COVID-19 Vaccine MAY be Available in the Fall